BRIEF-Orexigen Therapeutics announces new drug submission for Contrave in Canada By: Reuters: Company News April 25, 2017 at 02:30 AM EDT * Orexigen Therapeutics Inc announces new drug submission for Contrave© in canada Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.